NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Thursday a 64 percent dip in its second quarter revenues.

For the three months ended June 30, the Gaithersburg, Maryland-based microbial genetics testing and analysis firm reported $375,146 in revenues, down from $1.1 million for the same quarter a year ago.

OpGen's Q2 product sales rose to $319,171 from $272,538 in the year-ago period, while its laboratory services sales fell to $28,195 from $121,899. Meantime, revenues from collaborations fell to $27,780 from $677,780 year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.